Anderson J. Kermit has filed 4 insider transactions across 1 company since May 2023.
Most recent transaction: a grant/award of 9185 shares of ADIAL PHARMACEUTICALS, INC. ($ADIL) on April 07, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 7, 2026 | ADIAL PHARMACEUTICALS, INC. | $ADIL | Anderson J. Kermit | Director | A | Stock Option (Right to Buy) | 9185 | $0.00 | 9,185.0000 | 668,630 | 9999.99% | 1.37% |
| May 29, 2025 | ADIAL PHARMACEUTICALS, INC. | $ADIL | Anderson J. Kermit | Director | A | Stock Option (Right to Buy) | 28000 | $0.00 | 28,000.0000 | 6,539,760 | 9999.99% | 0.43% |
| March 25, 2024 | ADIAL PHARMACEUTICALS, INC. | $ADIL | Anderson J. Kermit | Director | A | Stock Option (Right to Buy) | 12000 | $0.00 | 12,000.0000 | 1,424,661 | 9999.99% | 0.84% |
| May 23, 2023 | ADIAL PHARMACEUTICALS, INC. | $ADIL | Anderson J. Kermit | Director | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 26,463,559 | 9999.99% | 0.19% |